GlassScriptPhysician profile
Stephen Savage
NPI 1669428553
$31,791.58
in general payments reported to CMS, 2019-2025
27 companies · $7,557 in 2025
The $7,557 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,403 · 2020: $434 · 2021: $547 · 2022: $11K · 2023: $1,589 · 2024: $8,554 · 2025: $7,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $3,920 · Travel and Lodging: $2,567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,212.55 |
| Food and Beverage | $3,919.50 |
| Travel and Lodging | $2,567.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $11,568.31 | 2019-2025 | Erleada |
| Intuitive Surgical, INC. | $7,992.98 | 2022-2025 | Da Vinci Surgical System |
| Merck Sharp & Dohme LLC | $4,360.00 | 2022 | |
| Boston Scientific Corporation | $3,147.76 | 2019-2025 | Lithovue, Moses, Lithovue Empower |
| Medtronic, INC. | $1,261.90 | 2024 | Signia |
| Tempus Ai, INC | $903.74 | 2024 | Xt Cdx |
| Lumenis, INC | $617.19 | 2019-2021 | |
| Procept Biorobotics Corporation | $493.57 | 2024-2025 | Aquabeam System |
| Ferring Pharmaceuticals INC. | $206.32 | 2024-2025 | Adstiladrin |
| Calyxo, INC. | $144.41 | 2025 | Cvac Aspiration System |
| Angiodynamics, INC. | $119.43 | 2025 | Nanoknife |
| Travere Therapeutics, INC. | $117.14 | 2019 | |
| Genzyme Corporation | $104.84 | 2022 | |
| Agiliti Surgical, INC. | $101.24 | 2025 | Quanta System Fiber Dust Tfl Laser, Olympus Soltive Tfl Laser, Sonablate Hifu |
| Coloplast Corp | $96.36 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $95.31 | 2023 | On-Q* Pump and Accessories |
| Ambu INC. | $94.36 | 2024 | |
| Cycle Pharmaceuticals INC | $94.18 | 2025 | Venxxiva |
| Olympus America INC. | $90.36 | 2024 | Itind System |
| Progenics Pharmaceuticals, INC. | $87.12 | 2024 | |
| Redhill Biopharma INC. | $81.76 | 2020 | |
| Alnylam Pharmaceuticals INC. | $13.30 | 2021 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Savage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.